Search

Frank Prendergast

Dr Frank Prendergast has a long and distinguished career in the US Healthcare industry with some of his more notable achievements as director for research at Mayo Clinic, member of the Board of Governors for Mayo Clinic and member of Mayo Clinic’s Executive Committee. Dr Prendergast has been a member of the Eli Lilly Company board of directors since 1995, and has served extensively in US National Institutes of Health in various capacities. Dr Prendergast has been non-executive director of Medibio and his vision is to use his extensive network in the US healthcare industry to expand Medibio’s advisory board, and as a platform to assist in the commercialisation of Medibio’s technology for the diagnosis of depression and other mental health disorders.
Bio last updated 16 Feb 2017

Access to our data for Frank Prendergast is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Frank Prendergast is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
471strent.com.au-8%-21%
512thSpectur-14%0%
516thTransaction Solutions International-14%-0%
837thMedibio-86%-21%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Roles

2016
Non-Executive Director
Year started and most recent title

Share Transactions

23/06/16
$0 Issued
23/06/16
$100k Issued
30/06/15
$0 Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

125th↓Crowdspark$2.5m
126th↑Spectur$2.5m
127th↓Medibio$2.5m
128th↑rent.com.au$2.5m
129th↑Transaction Solutions International$2.3m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer